Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-16T09:33:50.648Z Has data issue: false hasContentIssue false

Aripiprazole-Related Tardive Dyskinesia

Published online by Cambridge University Press:  07 November 2014

Abstract

The low prevalence of extrapyramidal symptoms associated with atypical antipsychotics has led to their widespread use during the past decade. Aripiprazole, the newest medication in this class, has been associated with extrapyramidal symptoms (eg, akathisia) and with improvement of tardive dyskinesia (TD), but to date it has not been associated with the development of TD. We report a case of TD associated with the use of aripiprazole 15 mg/day for 18 months for refractory depression. Symptoms of TD resolved within several weeks of discontinuation of aripiprazole.

Information

Type
Case Report
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable